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Methods: 126 STEMI patients were studied with 24 h continuous, 12-lead Holter monitoring.
Myocardial blush grade (MBG) was determined and VA bursts were identified against subject-specific
background VA rates in core laboratories. Delayed-enhancement cardiovascular magnetic resonance
imaging was used to determine infarct size.
Results: In the group with MBG 3 no significant differences were found for baseline characteristics
between burst versus no burst (102 vs. 24). In those with optimal epicardial and microvascular
reperfusion (TIMI 3, stable ST-recovery, and MBG 3), VA burst was associated with larger infarct
size (N = 102/126; median 11.0 vs. 5.1%; p = 0.004).
Conclusion: In the event of MBG 3, VA bursts were associated with significantly larger infarct size
even if optimal epicardial and microvascular reperfusion was present.
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concomitant with ST segment normalization in ST elevation
myocardial infarction (STEMI) were recognized as a sign of
reperfusion [1]. These reperfusion arrhythmias typically
consist of bursts of single or double ventricular premature
beats (with long coupling intervals to the preceding normally
conducted beats) and accelerated idioventricular rhythms.
Their QRS configuration is consistent with an origin from
the reperfused territory [1]. When primary PCI became
available it was found that in complete epicardial recanali-DE-CMR, delayed enhancement cardiovascular
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sevier Inc. All rights reserved.zation with TIMI 3 flow, these bursts of ventricular
reperfusion arrhythmias (VA bursts) were associated with
larger infarct size and decreased left ventricular function [2].
Since the advent of coronary revascularization it was
realized that just TIMI 3 flow was not sufficient to warrant
optimal recovery at myocellular level. Phenomena such as
distal embolization and damage at the microvascular level
may interfere with recurrence of myocellular function.
Therefore, although optimal epicardial recanalization
(i.e. TIMI 3 flow) was present, it was found that infarct
size also depended from more downstream existing markers,
such as blush, microvascular obstruction (MVO) and ST
segment recovery [3–7] Clinically, inadequate microvascu-
lar perfusion is independently associated with left ventricular
remodeling and mortality [8]. Myocardial blush grade
(MBG) is an angiographic classification to assess the
microvascular integrity status after epicardial flow restora-
tion (Fig. 1) and lower MBG is associated with larger infarct
size, decreased left ventricular ejection fraction (LVEF), and
increased mortality [9,10].
Fig. 1. Classification of myocardial blush grades.
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relation between MBG, VA bursts and final infarct size
measured by cardiac MRI, that even in patients with
optimal epicardial and microvascular recanalization VAs
indicate larger infarct size, identifying a more downstream,
at the myocellular level existing, source of cell death in
reperfused STEMI.Methods
Study population
Patients included in the “proximal embolic protection
study in patients undergoing primary angioplasty for acute
myocardial infarction” (PREPARE) trial were used for the
analyses. Since the Proxis™ proximal protection system
used in the PREPARE trial did not influence final infarct
size and LVEF [11], no distinction was made between the
treatment and control group. Approval was granted by the
Medical Ethical Committee of the Academic Medical Center
(ISRCTN71104460) and written informed consent was
obtained from all patients included. To study the ST-segment
and ventricular arrhythmia behavior, 24-h holter recording
starting before PCI was part of the study protocol.
The design of the PREPARE trial has been published
earlier [11]. In brief, in the PREPARE trial, primary PCI was
performed in patients with STEMI at the Academic Medical
Centre in Amsterdam, The Netherlands, between December
2006 and June 2008. Inclusion criteria were: (1) age 18 years
and above, (2) onset of symptoms ofmyocardial infarction less
than six hours before presentation, (3) persistent ST-segment
elevation of at least 2 mm in two or more contiguous leads on
initial ECG, and (4) TIMI-graded flow 0 to 1 on diagnostic
angiography. Exclusion criteria were: (1) any contraindication
to the use of glycoprotein IIb/IIIa receptor antagonists, (2) a
co-existent condition associatedwith a limited life expectancy,(3) prior coronary artery bypass grafting or administration of
thrombolytic agents, (4) the presenting STEMI being a
recurrence in the same myocardial area, and (5) proximal
LAD occlusion causing inability for the PROXIS device to
be used.
Exclusion criteria for ECG analysis were: (1) insufficient
holter recording quality for determining presence or absence
of VA burst either because of reperfusion before start of
holter recording or excess noise, (2) previous MI, (3)
inability to obtain cardiac magnetic resonance (CMR)
recordings or inconclusive CMR recording for infarct size
determination, (4) absence of successful epicardial flow
restoration defined as TIMI flow ≤2, (5) inability to obtain
stable ST recovery within 240 min, (6) late ST re-elevation,
and (7) MBG ≤ 2.
Angiographic TIMI flow and blush grade assessment
At the end of each primary PCI, a final coronary
angiogram was obtained. This post-procedural angiogram
was used to assess TIMI flow, angiographic signs of distal
embolization and the MBG by an independent observer at a
corelab (Cordinamo, Wezep, The Netherlands). Epicardial
coronary flow was assessed according the TIMI trial
classification [12]. Angiographic distal embolization was
defined as a filling defect, with an abrupt cut-off in the vessel
located distally from the infarct-related coronary lesion. The
assessment of myocardial blush grade was performed
according to van ‘t Hof et al. [10] (Fig. 1).
ECG data acquisition
Continuous 12-lead ECG Holter recording (NEMON
180+, Northeast Monitoring, Maynard, MA, USA) was
started immediately after admission and prior to the first
angiogram. The NEMON system records a standard digital
12-lead ECG every 60 s in high-fidelity 720 Hz mode while
Fig. 2. Example of a patient with and a patient without VA burst. Concomitantly acquired coronary angiography assessments of pre- and post-primary
percutaneous coronary intervention TIMI flow grades in two study subjects (1 A and 2 A) with a total occlusion in the proximal left anterior descending artery
proximal (LAD); continuous digital 12-lead electrocardiography monitoring for ST-segment recovery analysis with both subjects having ≥50% stable
ST-segment recovery (1B and 2B); and complete beat-to-beat Holter monitoring for quantitative rhythm analysis identifying (1C) or not identifying (2C
patient-specific ventricular arrhythmia ‘bursts’ by using independent statistical outlier detection methodology. Cx = circumflex artery; LMA = left margina
artery. (Majidi et al. Eur. Heart J 2009;30:757–764).
347K. van der Weg et al. / Journal of Electrocardiology 49 (2016) 345–352simultaneously archiving beat-to-beat Holter rhythm on a
digital clock synchronized to the catheterization laboratory
clock for accurate correlation of ECG changes, and holter
rhythm changes. Continuous digital ECG and Holter data
were encrypted and blinded to the clinical team and sent to the
eECG core laboratory (eECG Core Laboratory, Maastricht
University Medical Centre, Maastricht, The Netherlands) for
independent blinded quantitative rhythm analysis.Continuous ST recovery analysis
Method and criteria for continuous 12-lead ST-segment
recovery analysis and reperfusion of the culprit lesion have
been described in detail previously [6]. In short, peak
ST-segment deviation is determined based on the lead with
the greatest deviation taken from the most abnormal ECG
recorded during monitoring. Steady state recovery was deter-
mined as N50% recovery from previous peak ST-segment levels
in the most deviated lead, lasting N4 h without further
ST-segment evolution (N100 uV) and patients were excluded
from further analysis if time from last contrast injection to steady
state was 240 min or more. Late ST elevation was diagnosed
when recurrent ischemia following the first sustained 50%)
lrecovery (stable reperfusion) occurs with re-elevation of 150 uV,
relative to the immediate previous recovery or baseline ST level in
the most abnormal lead, occurring after stable reperfusion.
Quantitative rhythm analysis
For beat-to-beat quantitative rhythm analysis on all digital
3-lead holter recordings, holter 5 software (Northeast
Monitoring, Maynard, MA, USA) was used [13]. All
automatically assigned waveform labels were manually
verified for each cardiac cycle from each subject to ensure
accurate VA capture according to predefined criteria for
ECG interpretation of VAs [13,14]. Fusion beats (normally
conducted ventricular activation fused with ventricular
premature complex (VPC) morphology) were also consid-
ered VPC's. To generate quantitative VA rates over a 24 h
period, total VPC counts were bundled into 5 min blocks for
temporal correlation with stable ST-segment recovery and
angiographic observations (Fig. 2).
Defining VA burst
Quantitative VA rates over the course of Holter
recordings were incorporated in a statistical outlier detection
Table 1
Patient characteristics.
MBG 3
Burst not present (N = 24) Burst present (N = 102) P
Demographics
age (years) 56.0 SD 8.5 57.8 SD 11.2 0.46
Male 23 95.8% 82 80.4% 0.08
Comorbidities
BMI 27.2 SD 4.0 26.7 SD 3.8 0.60
Smoking current 14 58.3% 64 62.7% 0.80
Previous 5 20.8% 17 16.7%
History of hypertension 6 25.0% 21 20.6% 0.59
Diabetes mellitus 2 8.3% 6 5.9% 0.65
Hypercholesteremia 3 12.5% 14 13.7% 1.00
Positive family history 7 29.2% 41 40.2% 0.36
Pre-existent AP 2 8.3% 3 2.9% 0.24
History of stroke 0 0.0% 2 2.0% 1.00
Peripheral artery disease 0 0.0% 2 2.0% 1.00
Medication
β-blocker 3 12.5% 10 9.8% 0.71
acetyl salic acid 2 8.3% 9 8.8% 1.00
ADP-antagonist 0 0.0% 1 1.0% 1.00
Statin 4 16.7% 10 9.8% 0.47
Nitrates 0 0.0% 0 0.0%
ACE-inhibitor 1 4.2% 4 3.9% 1.00
AT-II antagonist 2 8.3% 7 6.9% 0.68
Calcium-antagonist 4 16.7% 4 3.9% 0.04⁎
PCI
Anterior MI 4 16.7% 27 26.5% 0.43
Multiple vessel disease 10 41.7% 30 29.4% 0.38
PCI of N1 lesion 0 0.0% 1 1.0% 1.00
Distal embolization 2 8.3% 11 10.8% 1.000
Duration of symptoms (min)a 173.0 SD 69.0 184.8 SD 91.5 0.57
ACE = angiotensin converting enzyme, ADP = adenosine diphosphate, AP = angina pectoris, AT = angiotensin, BMI = body mass index, CMR =
cardiovascular magnetic resonance imaging, MBG = myocardial blush grade, MVO = microvascular obstruction, PCI = percutaneous coronary intervention
⁎ significant difference.
a duration of symptoms from onset till first balloon time.
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bursts’), from subject-specific background VA counts.
Reperfusion VA bursts were identified as such if they
occurred concomitantly with or subsequently to angiograph-
ic documentation of re-established TIMI 3 flow in the infarct
related artery. Study subjects were dichotomously classified
into the ‘reperfusion VA burst’ group or the ‘no-VA burst’
group based on having a significantly higher incidence of
ventricular arrhythmias than background ventricular arrhyth-
mias. This is illustrated in Fig. 2 panel 1C and 2C where over
24 h continuous ventricular activation is observed (“back-
ground arrhythmias”), but in panel 1C interrupted by a
sudden increase in ventricular arrhythmias (“VA burst”),
which was statistically identified using an outlier method-
ology as outlined in the supplement to this manuscript [13].Cardiac Magnetic Resonance protocol
CMR examination was performed on a 1.5 T clinical
scanner (Sonato/Avanto, Siemens, Erlangen, Germany),
with the patient in a supine position, using a phased array
cardiac receiver coil. ECG-gated cine images were acquired
using a breath-hold segmented steady-state free precession.sequence (echo time/repetition time of 1.2/3.2 ms; spatial
resolution of 1.3 3 1.8 3 5 mm). Per patient short-axis views
were obtained every 10 mm starting from base to apex and
including the entire left ventricle. Late gadolinium
enhancement images were obtained 10-15 min after the
administration of a gadolinium-based contrast agent
(Magnevist, Schering AG, Berlin, Germany; 0.2 mmol/kg)
using a two-dimensional segmented inversion recovery
gradient echopulse sequence (repetition time/echo time 9.6/
4.4 ms, spatial resolution 1.6 3 1.3 3 5.0 mm), with slice
position identical to the cine images. The inversion time was
set to null the signal of viable myocardium and typically
ranged from 250 to 300 ms. All data were analyzed using a
dedicated software package (MASS 5.1) and by one
experienced investigator who was blinded to the patient data.
Left ventricular volumes were determined by planimetry of all
short axis images in each patient and the left ventricular
ejection fraction was calculated. The delayed gadolinium
enhancement (DE)-CMR images and final infarct size were
assessed described previously [15]. In brief, final infarct size
was calculated by automatic summation of all slice volumes of
hyper enhancement (signal intensity N6 SD above the mean
signal intensity of remote myocardium).
Fig. 3. Patient selection. Patient selection of combined dataset with reasons
for exclusion.CMR = cardiac magnetic resonance, MBG = myocardial
blush grade, PCI = percutaneous coronary intervention, TIMI = thrombolysis
in myocardial infarction.
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Univariable comparisons for patient characteristics and
outcomes between patients with and patients without VA
bursts were made using independent student t-test for
parametric variables, Wilcoxon rank sum test for non-
parametric variables, and Fisher exact test for dichotomous
variables. The same was done in subgroup analysis of
patients with blush 3 grade. A p value of b0.05 wasconsidered statistically significant and all statistical tests
were two-sided.
Multivariable linear regression analysis was performed to
assess whether VA burst remained an independent predictor
for infarct size and LVEF if corrected for covariates. The
dependent variable was infarct size determined by DE-CMR.
Covariates were selected by including known predictors for
infarct size, displayed in Table 1, in the multivariate model
and using the backwards stepwise model excluding those
with p values N0.15. Covariates were added to a regression
model starting with VA burst and presence or absence of
blush grade 3. Data were analyzed using IBM SPSS statistics
software version 19.Results
The PREPARE study population consists of 206 patients,
of whom 7 were excluded because of previous myocardial
infarction, 15 patients had inadequate Holter recordings for
VA burst determination, 13 patients did not obtain TIMI 3
flow after PCI, 12 were excluded because of insufficient
CMR quality for infarct size determination, 19 had no stable
ST recovery within 240 min or had late ST re-elevation, and
14 had MBG ≤ 2 (Fig. 3). The remaining 126 patients were
used for analysis.
Table 1 shows patients characteristics according to the
presence or absence of VA burst. The mean age was between
56 and 58 years in the respective groups and did not
significantly differ. Most of the patients were male (80–
96%) and VA burst occurred in 81.0% (102/126). No
significant differences were found regarding baseline
characteristics between the presence or absence of VA
burst, except for the use of calcium antagonists. Patients who
used a calcium antagonist before STEMI had on average a
lower incidence of VA burst (4% vs 17%; p = 0.04).
DE-CMR was performed within a median of 207 days
(25%-75% quartiles; 135–365 days).
In case of optimal microvascular reperfusion (MBG 3),
but with VA burst, infarct size doubled (11.0 vs. 5.1%; p =
0.004) compared to no VA burst (Fig. 4). Due to the
relatively small infarcts in this study population LVEF was
not significantly affected by the all or none presence of VA
burst. In multivariable analysis the correlation between VA
burst and infarct size remained significant (B = 3.8; p =
0.04) when correcting for other known predictors of infarct
size, such as anterior wall location, age, and the use of
β-blockers or ACE-inhibitors before the event (Table 2). In
the multivariable analyses there was no significant effect of
the use of calcium-antagonists before the event.Discussion
This study shows that in the case of TIMI-3 flow and
optimal microvascular reperfusion as indicated by TIMI-3
flow, stable ST-recovery and MBG 3, in patients with
VA burst, infarct size was twice as large as those without
VA burst.
Fig. 4. Differences between VA burst present or absent. Box plots with
corresponding medians and quartiles displaying the effect VA burst in the
presence of optimal myocardial blush grade (MBG 3).
Table 2
Multivariable analysis for final infarct size in patients with optimal blush
grade.
Coefficient 95% CI P-value
Presence of VA burst 3.8 0.2 - 7.4 0.040
Anterior location 8.7 5.4 - 12.0 0.000
β-blocker use before event −4.8 −9.5 - −0.1 0.045
ACE-inhibitor used before 7.7 0.4 - 15.0 0.039
Patient's age in years 0.1 −0.01 - 0.25 0.080
Constant −8.9 −17.8 - −0.1 0.048
R2 = 0.27.
ACE = angiotensin converting enzyme.
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electrobiomarker for the success of reperfusion and infarct
size after recanalization attempts in STEMI [6,7]. This study
suggests that addition of the presence of VA burst further
refines the prognostic model that identifies myocardial
salvage and infarct size. VA burst has been shown to be a
marker for larger infarct size, as measured by SPECT, in
anterior wall STEMI [14,16]. Our results confirm previous
findings using the more accurate measurement of DE-CMR
[17]. Previous models of reperfusion VA burst depended on
99mTc-sestamibi SPECT to quantify the infarct size
endpoint. SPECT is well validated in larger MI's, however
is less reliable in smaller MI's with lower sensitivity for
scintigraphic defects below 10 g of infarcted tissue [18].
DE-CMR, on the other hand, has superior spatial resolution
and is superior in detecting smaller infarcts, such as
subendocardial infarcts and infarcts in non-anterior locations
[19,20]. Our results show that final infarct size is was in
general relatively small, especially in non-anterior infarcts,
in the setting of fast ST-recovery and optimal TIMI flow and
blush grade. By using a more accurate method such as
DE-CMR we could confirm results from a previous
study that used SPECT, even in our population with small
infarcts [16].
Until now it was not known whether VA bursts were
markers either of suboptimal microvascular reperfusion,
larger areas at risk or another pathophysiological mechanism
such as reperfusion injury. This is the first study to describe
that VA bursts indicate larger infarct size in the presence of
not only optimal epicardial but also optimal (MBG
determined) microvascular reperfusion directly after reper-
fusion by PCI using DE-CMR. There are neverthelessexperimental reports showing a progression of microvascular
obstruction (MVO) over the hours after reperfusion [21,22].
However CMRwas performed after the (sub)acute phase and
the difference in infarct size between the burst and no burst
group remained. To exclude the involvement of suboptimal
microvascular perfusion in the presence of VA burst and its
correlation with infarct size, the hypothesis should also be
tested in a population using MVO diagnosed by DE-CMR as
a marker of impaired microvascular integrity. Moreover, the
influence of the initial area at risk on the presence of VA
burst should be tested to exclude an interaction for the
outcome of infarct size. These questions are currently being
studied by our group in ongoing research.
In the event of optimal epicardial reperfusion and optimal
MBG, the occurrence of VA burst appeared a marker for
larger infarct size. As such VA burst may be a potential
useful biomarker for larger infarct size and worse outcome
next to current markers of TIMI flow, stable ST recovery
within 240 min, and myocardial blush grade. Such an
additional biomarker could be useful in the early identifica-
tion of patients at higher risk following recanalization
attempts. “VA burst in our study was defined by a statistical
outlier method, a burst of ventricular arrhythmias being
differentiated from background arrhythmias using a 24 h
holter recording. In clinical practice such a long recording
time will likely not be needed as the occurrence of
reperfusion arrhythmia burst can already be readily observed
in the cath lab. However it is desirable to develop a robust
algorithm enabling automatic assessment of “burst” or “no
burst”. Therefore, further research studying shorter
observation times to quantify background arrhythmias
should be done.”Limitations
One of the limitations of our study was a relatively small
study population, yet, VA bursts were accurately assessed
using continuous Holter monitoring and manual validation
and infarct size was assessed using the current standard MRI.
We did not have sufficient data regarding enzymatic infarct
size because more than 50% of the population was referred
back to the non-intervention hospitals in the region shortly
after the recanalization procedure and enzymatic data from
those hospitals was limited.
351K. van der Weg et al. / Journal of Electrocardiology 49 (2016) 345–352The number of patients with an anterior myocardial
infarction was small in our study population. This is
probably due to the exclusion of proximal LAD infarcts
because of the inability to use the Proxis device in these
laesions. Although the use of the Proxis device did not
influence infarct size it did however exclude a part of the
anterior infarctions.
We did not analyze the additional effect of medication
given post myocardial infarction on final infarct size at the
time of CMR. Because medication given after myocardial
infarction is protocollized according to the ESC guidelines
throughout the Netherlands we assume that it did not cause
significant effect on infarct size between patients. However,
we did not test this assumption.
For unknown reasons our study group showed a marked
male preponderance. Therefore it is not certain whether the
results can be transponed to a female population.
MBG as a marker for microvascular obstruction has some
limitations and MVO on DE-CMR is currently being
considered the preferred method. However, MBG directly
after PCI is an intrinsically and early obtainable angiographic
marker, while MVO on DE-CMR requires additional
equipment and patient related suitability.Conclusion
This is the first study to show that infarct size as measured
by CMR is significantly larger in the occurrence of VA burst
upon reperfusion in both anterior and non-anterior myocar-
dial infarction, not only in the presence of optimal epicardial
reperfusion but also when optimal microvascular reperfusion
is present as defined by MBG 3. This suggests the cause of
the larger damage to be localized at the myocellular level.Funding sources
This work was supported by funding from the Hein
Wellens Foundation, Maastricht, and from the Academic
Medical Center - University of Amsterdam, the Netherlands.Disclosures
The authors have no conflicts of interest to declare.
Acknowledgements
The authors wish to thank the Hein Wellens Foundation
for their support in this project.
References
[1] Gorgels AP, Vos MA, Letsch IS, Verschuuren EA, Bar FW, Janssen JH,
et al. Usefulness of the accelerated idioventricular rhythm as a marker for
myocardial necrosis and reperfusion during thrombolytic therapy in acute
myocardial infarction. Am J Cardiol 1988;61(4):231–5.
[2] EngelenDJ, Gressin V, Krucoff MW, Theuns DA, Green C, Cheriex EC,
et al. Usefulness of frequent arrhythmias after epicardial recanalization in
anterior wall acute myocardial infarction as a marker of cellular injury
leading to poor recovery of left ventricular function. Am J Cardiol
2003;92(10):1143–9.[3] Ibanez B, Heusch G, Ovize M, Van de Werf F. Evolving Therapies for
Myocardial Ischemia/Reperfusion Injury. J Am Coll Cardiol
2015;65(14):1454–71.
[4] Eitel I, de Waha S, Wohrle J, Fuernau G, Lurz P, Pauschinger M, et al.
Comprehensive prognosis assessment by CMR imaging after ST-
segment elevation myocardial infarction. J Am Coll Cardiol
2014;64(12):1217–26.
[5] Krucoff MW, Croll MA, Pope JE, Granger CB, O'Connor CM,
Sigmon KN, et al. Continuous 12-lead ST-segment recovery analysis
in the TAMI 7 study. performance of a noninvasive method for real-
time detection of failed myocardial reperfusion. Circulation
1993;88(2):437–46.
[6] Krucoff MW, Croll MA, Pope JE, Pieper KS, Kanani PM, Granger CB,
et al. Continuously updated 12-lead ST-segment recovery analysis for
myocardial infarct artery patency assessment and its correlation with
multiple simultaneous early angiographic observations. Am J Cardiol
1993;71(2):145–51.
[7] Sattur S, Sarwar B, Sacchi TJ, Brener SJ. Correlation between markers
of reperfusion and mortality in ST-elevation myocardial infarction: a
systematic review. J Invasive Cardiol 2014;26(11):587–95.
[8] Wong DT, Leung MC, Richardson JD, Puri R, Bertaso AG, Williams
K, et al. Cardiac magnetic resonance derived late microvascular
obstruction assessment post ST-segment elevation myocardial infarc-
tion is the best predictor of left ventricular function: a comparison of
angiographic and cardiac magnetic resonance derived measurements.
Int J Cardiovasc Imaging 2012;28(8):1971–81.
[9] Hoffmann R, Haager P, Arning J, Christott P, Radke P, Blindt R, et al.
Usefulness of myocardial blush grade early and late after primary
coronary angioplasty for acute myocardial infarction in predicting left
ventricular function. Am J Cardiol 2003;92(9):1015–9.
[10] AW van ‘t Hof, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ,
Zijlstra F. Angiographic assessment of myocardial reperfusion in patients
treated with primary angioplasty for acute myocardial infarction:
myocardial blush grade. Zwolle Myocardial Infarction Study Group.
Circulation 1998;97(23):2302–6.
[11] Haeck JD, Kuijt WJ, Koch KT, Bilodeau L, Henriques JP, Rohling WJ, et
al. Infarct size and left ventricular function in the PRoximal embolic
protection in acute myocardial infarction and resolution of ST-segment
elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance
study. Heart 2010;96(3):190–5.
[12] The Thrombolysis inMyocardial Infarction (TIMI) trial. Phase I findings.
TIMI Study Group. N Engl Reg Allergy Proc 1985;312(14):932–6.
[13] Majidi M, Kosinski AS, Al-Khatib SM, Lemmert ME, Smolders L, van
Weert A, et al. Reperfusion ventricular arrhythmia ‘bursts’ in TIMI 3
flow restoration with primary angioplasty for anterior ST-elevation
myocardial infarction: a more precise definition of reperfusion
arrhythmias. Europace 2008;10(8):988–97.
[14] Majidi M, Kosinski AS, Al-Khatib SM, Lemmert ME, Smolders L, van
Weert A, et al. Reperfusion ventricular arrhythmia ‘bursts’ predict
larger infarct size despite TIMI 3 flow restoration with primary
angioplasty for anterior ST-elevation myocardial infarction. Eur Heart
J 2009;30(7):757–64.
[15] Hirsch A, Nijveldt R, Haeck JD, Beek AM, Koch KT, Henriques JP, et
al. Relation between the assessment of microvascular injury by
cardiovascular magnetic resonance and coronary Doppler flow
velocity measurements in patients with acute anterior wall myocardial
infarction. J Am Coll Cardiol 2008;51(23):2230–8.
[16] Majidi M, Kosinski AS, Al-Khatib SM, Smolders L, Cristea E, Lansky
AJ. Implications of ventricular arrhythmia "bursts" with normal
epicardial flow, myocardial blush, and ST-segment recovery in
anterior ST-elevation myocardial infarction reperfusion: A biosigna-
ture of direct myocellular injury "downstream of downstream". Eur
Heart J Acute Cardiovasc Care 2015;4(1):51–9.
[17] van der Weg K, Kuijt WJ, Tijssen JG, Bekkers SC, Haeck JD, Green
CL, et al. Prospective evaluation of where reperfusion ventricular
arrhythmia “bursts” fit into optimal reperfusion in STEMI. Int J Cardiol
2015 [accepted for publication].
[18] Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction
redefined–a consensus document of the joint European society Of
cardiology/American college Of cardiology committee for the
352 K. van der Weg et al. / Journal of Electrocardiology 49 (2016) 345–352redefinition of myocardial infarction. J Am Coll Cardiol
2000;36(3):959–69.
[19] IbrahimT, BulowHP, Hackl T, HornkeM, Nekolla SG, BreuerM, et al.
Diagnostic value of contrast-enhancedmagnetic resonance imaging and
single-photon emission computed tomography for detection
of myocardial necrosis early after acute myocardial infarction. J Am
Coll Cardiol 2007;49(2):208–16.
[20] Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker
M, et al. Contrast-enhanced MRI and routine single photon emission
computed tomography (SPECT) perfusion imaging for detection ofsubendocardial myocardial infarcts: an imaging study. Lancet
2003;361(9355):374–9.
[21] Reffelmann T, Kloner RA. Microvascular reperfusion injury:
rapid expansion of anatomic no reflow during reperfusion in
the rabbit. Am J Physiol Heart Circ Physiol Sep 2002;283(3):
H1099–107.
[22] Rochitte CE, Lima JA, BluemkeDA, Reeder SB,McVeigh ER, Furuta T,
et al. Magnitude and time course of microvascular obstruction and tissue
injury after acute myocardial infarction. Circulation 1998;98(10):
1006–14.
